investigational medicines

Becraft
Favicon Fierce Biotech

Strand Tx CEO Jake Becraft weighs in on FDA's IND reform, China

The Strand Therapeutics CEO and BIO board director warned that the U.S. must modernize its regulatory framework for early-stage clinical trials.
Angus Liu May 4, 2026 12:00pm
FDA Building

Pharma ad police issues first warning of 2019

Mar 15, 2019 11:25am